MET and cancer: Conversely, in ovarian [54] and gastric [56] cancer cell lines that display basal MET phosphorylation, MET inhibition with capmatinib [54] or PHA-665752 [56], in combination with paclitaxel [54] or adriamycin [56], has been shown to lead to accumulation of DSBs compared to chemotherapy alone.